Literature DB >> 11304830

Further evidence for linkage of Gilles de la Tourette syndrome (GTS) susceptibility loci on chromosomes 2p11, 8q22 and 11q23-24 in South African Afrikaners.

I Simonic1, D R Nyholt, G S Gericke, D Gordon, N Matsumoto, D H Ledbetter, J Ott, J L Weber.   

Abstract

Utilizing DNA samples from 91 Afrikaner nuclear families with one or more affected children, five genomic regions on chromosomes 2p, 8q, 11q, 20q, and 21q that gave evidence for association with GTS in previous case-control association studies were investigated for linkage and association with GTS. Highly polymorphic markers with mean heterozygosity of 0.77 were typed and resulting genotypes evaluated using single marker transmission disequilibrium (TDT), single marker haplotype relative risk (HRR), and multi-marker "extended" TDT and HRR methods. Single marker TDT analysis showed evidence for linkage or association, with p-values near 0.05, for markers D2S139, GATA28F12, and D11S1377 on chromosomes 2p11, 8q22 and 11q23-24, respectively. Extended, two-locus TDT and HRR analysis provided further evidence for linkage or association on chromosome 2 with p-values of 0.007 and 0.025, and chromosome 8 with p-values of 0.059 and 0.013, respectively. These results provide important additional evidence for the location of GTS susceptibility loci. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11304830     DOI: 10.1002/ajmg.1192

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  16 in total

1.  Translocation breakpoint in two unrelated Tourette syndrome cases, within a region previously linked to the disorder.

Authors:  Fiona C Crawford; Ghania Ait-Ghezala; Mark Morris; Maxine J Sutcliffe; Robert A Hauser; Archie A Silver; Michael J Mullan
Journal:  Hum Genet       Date:  2003-04-16       Impact factor: 4.132

2.  Indications of linkage and association of Gilles de la Tourette syndrome in two independent family samples: 17q25 is a putative susceptibility region.

Authors:  P Paschou; Y Feng; A J Pakstis; W C Speed; M M DeMille; J R Kidd; B Jaghori; R Kurlan; D L Pauls; P Sandor; C L Barr; K K Kidd
Journal:  Am J Hum Genet       Date:  2004-08-09       Impact factor: 11.025

Review 3.  The genetics of Tourette syndrome.

Authors:  Hao Deng; Kai Gao; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2012-03-13       Impact factor: 42.937

Review 4.  An update on Tourette syndrome.

Authors:  Thomas E Kimber
Journal:  Curr Neurol Neurosci Rep       Date:  2010-07       Impact factor: 5.081

5.  Chromosomal rearrangements in Tourette syndrome: implications for identification of candidate susceptibility genes and review of the literature.

Authors:  Birgitte Bertelsen; Nanette Mol Debes; Lena E Hjermind; Liselotte Skov; Karen Brøndum-Nielsen; Zeynep Tümer
Journal:  Neurogenetics       Date:  2013-08-29       Impact factor: 2.660

6.  Efficacy of Glutamate Modulators in Tic Suppression: A Double-Blind, Randomized Control Trial of D-serine and Riluzole in Tourette Syndrome.

Authors:  Monica E Lemmon; Marco Grados; Tina Kline; Carol B Thompson; Syed F Ali; Harvey S Singer
Journal:  Pediatr Neurol       Date:  2015-02-19       Impact factor: 3.372

7.  Association of the KCNJ5 gene with Tourette Syndrome and Attention-Deficit/Hyperactivity Disorder.

Authors:  L Gomez; K Wigg; K Zhang; L Lopez; P Sandor; M Malone; C L Barr
Journal:  Genes Brain Behav       Date:  2014-06-19       Impact factor: 3.449

8.  Genomewide scan of hoarding in sib pairs in which both sibs have Gilles de la Tourette syndrome.

Authors:  Heping Zhang; James F Leckman; David L Pauls; Chin-Pei Tsai; Kenneth K Kidd; M Rosario Campos
Journal:  Am J Hum Genet       Date:  2002-02-11       Impact factor: 11.025

9.  Genome-wide prediction of imprinted murine genes.

Authors:  Philippe P Luedi; Alexander J Hartemink; Randy L Jirtle
Journal:  Genome Res       Date:  2005-06       Impact factor: 9.043

10.  Latent class analysis of gilles de la tourette syndrome using comorbidities: clinical and genetic implications.

Authors:  Marco A Grados; Carol A Mathews
Journal:  Biol Psychiatry       Date:  2008-03-21       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.